Tevogen shareholders approve 100M share increase to 2024 incentive plan and written consent amendment

Tevogen Bio Holdings Inc.

Stockholders approved Plan Amendment increasing shares available under 2024 Omnibus Incentive Plan by 100,000,000 to 102,800,000 initial limit.
Approved charter amendment permitting stockholder action by written consent, effective Aug 26, 2026.
Elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors for three-year terms.
Ratified KPMG LLP as independent auditor for fiscal year ending Dec 31, 2026.
Votes: Plan Amendment 5,322,668 for; charter amendment 5,382,051 for; quorum 5,956,141 shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.